Question 1

Has Hong Chen received payments from drug or device companies?

Accepted Answer

Yes. Drug and device makers reported $56,511 in general payments to Hong Chen across 871 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Question 2

Does a payment mean Hong Chen did something wrong?

Accepted Answer

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Question 3

Where does this information about Hong Chen come from?

Accepted Answer

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Company	Payments	Total
Gilead	152	$22,331
Phathom Pharmaceuticals, Inc.	38	$10,826
IBSA Pharma Inc.	38	$4,701
AbbVie	95	$2,851
Amgen(2 entities)	87	$2,645
Esperion Therapeutics, Inc.	68	$2,321
Biohaven Pharmaceuticals, Inc.	21	$2,084
Boehringer Ingelheim	54	$1,503
AstraZeneca	43	$1,258
Novo Nordisk	32	$1,002
GSK	39	$989
Biohaven Pharmaceutical Holding Company Ltd.	27	$804
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	52	$727
Amarin Pharma, Inc.	27	$576
Pfizer	21	$387
Aimmune Therapeutics, Inc.	21	$342
Bayer	13	$260
Lilly USA, LLC	10	$252
Nestle Healthcare Nutrition Inc.	10	$162
Novartis	7	$161
Ironwood Pharmaceuticals, Inc	5	$113
Sumitomo Pharma America, Inc.	4	$80
Corcept Therapeutics	3	$67
Biogen	3	$53
Ipsen Biopharmaceuticals, Inc	1	$14

Hong Chen

Payments from drug & device makers

Who reported the general payments

How this compares

Other physician assistant in Brooklyn